Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: J Thorac Imaging. 2013 Sep;28(5):10.1097/RTI.0b013e31829f6796. doi: 10.1097/RTI.0b013e31829f6796

Development of Quantitative CT Lung Protocols

John D Newell Jr 1, Jered Sieren 1, Eric A Hoffman 1
PMCID: PMC3876949  NIHMSID: NIHMS503532  PMID: 23934142

Abstract

The purpose of this paper is to review the process of developing optimal CT protocols for quantitative lung CT. This will include discussions of the following important topics; QCT derived metrics of lung disease, QCT scanning protocols and quality control and QCT image processing software.

We will briefly discuss several QCT derived metrics of lung disease that have been developed for the assessment of emphysema, small airway disease and large airway disease.

The CT scanning protocol is one of the most important elements of successfully performing QCT. We will provide a detailed description of the current thinking on optimizing the QCT protocol for the assessment of COPD and Asthma. Quality control of the CT images is also a very important part of the QCT process and we will discuss why it is necessary to use CT scanner test objects (phantoms) to provide frequent periodic checks on the CT scanner calibration to assure precise and accurate CT numbers are obtained.

We will discuss the use of quantitative CT image processing software to segment the lung and extract the desired QCT metrics of lung disease. We will discuss the practical issues of using this software. The data obtained from the image processing software is then combined with other clinical information, health status questionnaires, pulmonary physiology and genomic data to increase our understanding of obstructive lung disease and to improve our ability to design new therapies for these diseases.

Keywords: CT, computed tomography, quantitative, quantitative CT protocol, lung, pulmonary, COPD, asthma

Introduction

The purpose of this paper is to review the process of developing optimal CT protocols for quantitative lung CT. This will include discussions of the following important topics; QCT derived metrics of lung disease, QCT scanning protocols and quality control and QCT image processing software.

QCT derived metrics of lung disease are based on using CT derived measures of intensity/density, texture, volume, perfusion, ventilation and mechanics of lung tissue. It is also based on looking at airway geometry to assess thickness of the airway walls and also narrowing or enlargement of the airway lumen.

QCT imaging of the lung has been used to quantitate lung intensity/density and airway geometry in the normal adult human lung1. QCT has been used to assess smoking related lung disease including emphysema and large airway disease27. QCT has been used to assess air trapping in asthma patients4, 5, 810. QCT has also been used to assess Interstitial lung disease1115, lung nodules1622, radiation induced lung injury2326, and both lung perfusion and ventilation2730, but for the purposes of this review we will focus on QCT intensity/density and airway geometry measures of smoking related lung disease and asthma.

There have been several large multi-center trials that have used QCT to assess the effects of smoking induced emphysema, small airway disease and airway remodeling of large airways. These include the following NIH-NHLBI funded multi-center research studies; Genetic Epidemiology of COPD (COPDGene) phase 1 and phase 2, Multi-Ethnic Study in Atherosclerosis (MESA), Subpopulations and intermediate outcome measures in COPD (SPIROMICS). Severe Asthma Research Program (SARP) I, II and III are multi-center research trials that have studied severe asthma patients for using QCT assessments of large and small airway disease.

There have been many iterations of the CT scanning protocol thought to be optimal for QCT assessment of COPD and asthma but the most recent widely accepted QCT protocol for COPD and asthma was designed for the SPIROMICS study and is called the SPIROMICS CT protocol. The important issues that need to be considered in building a robust QCT scanning protocol will be discussed in this review. We will also discuss QCT scanning quality control procedures using manufacturer supplied test objects/phantoms and the COPDGene 1 test object.

QCT image processing software available for the analysis of CT images include PASS (University of Iowa), Apollo Workstation 2 (VIDA Diagnostics, Inc.), Airway Inspector for SLICER (Harvard University). There are several other packages available. We will illustrate the kind of image processing that is output from these programs to provide the QCT metrics necessary to phenotype lung disease.

Quantitative CT Metrics of Lung Disease

The images that are obtained from single breath hold MDCT images of the lungs are made up of individual voxels each assigned an average value for the linear attenuation of lung tissue within that voxel. The linear attenuation values are expressed in a practical unit called the Hounsfield Unit (HU). The CT attenuation values expressed in HU’s have a range from −1000 HU to +3095 HU on 12 bit CT scanners. −1000 HU is the value for pure air. 0 HU is the value for pure water. 40 HU is the value for blood. +1000 HU or greater is the value of cortical bone. Analysis of the linear attenuation values assigned to the lung voxels provides the basis for quantitative CT assessment of different tissues including lung tissue.

Several quantitative CT derived metrics of obstructive lung disease have been published in the literature. These include the percent of lung tissue having a density less than −950 HU on a TLC CT scan which is a marker of emphysema2, 3, 31, 32. The percent of lung tissue having a density less than −856 HU on a FRC/RV CT lung scan which is a marker of air trapping and by inference small airway disease8, 9. The ratio of the mean lung density at FRC to the mean lung density at TLC, E/I mean lung density ratio, is also a valuable measure of air trapping and possibly better than the −856 HU threshold method just mentioned33. The percent bronchial wall area for a given generation of lung airway is a measure of large airway remodeling, usually thickening, and has been used in a number of QCT studies of COPD and Asthma subjects with success in predicting large airway abnormalities2, 18, 20, 32, 34. These example indices provide CT derived quantitative imaging metrics of certain features of obstructive lung disease. In order to reduce radiation dose to subjects or patients a new method of CT image reconstruction has been introduced that is known as iterative reconstruction. These techniques have come out from multiple CT manufacturers and have been readily accepted by the broad qualitative 3D lung imaging community. There has been concern in the QCT scanning community that these new techniques may introduce inaccuracies in the CT number measurements. Recent work suggests this may not be the case35. Further work is ongoing in this area by multiple QCT research groups including our own.

The value of these QCT metrics of obstructive lung disease can only be assured if precise and accurate measurements are made on each subject or patient. QCT is much more rigorous than qualitative 3D visualization of the lung since the quantitative indices can vary in value based on lung volumes, CT scan parameters and CT scanner calibration. In the next section we will discuss in detail the important aspects of QCT scanning protocols, CT scanner calibration and ways to assure the patient is scanned at the desired lung volume, e.g. TLC or FRC/RV.

Quantitative CT Scanning Protocol and Quality Control

QCT of the lung provides exciting new metrics of lung disease that are not available in qualitative 3D CT visualization of lung disease. The two are complimentary, but QCT is much more rigorous than qualitative 3D visualization CT since we are relying on accurate and precise measures of lung density to derive a number of metrics as mentioned in the last section. Ideally, there would be one CT scanner and software system using exactly the same parameters specified in the QCT scanning protocol to reconstruct images of the lungs on all subjects in a clinical trial to study COPD or Asthma. Unfortunately, this is not possible because in order to recruit the necessary number of subjects to adequately power the research goals of the trial multiple centers must be involved. Also, CT technology is rapidly evolving so over the period of a multi-center trial, 4–5 years, the participating centers will upgrade their CT scanners to new machines with different methods of generating the attenuation values assigned to the individual voxels. These two issues make the development of a robust quantitative CT scanning protocol a challenge.

The approach to designing an optimal QCT protocol for a particular study is as follows:

  • Scan at a known lung volume, e.g. TLC, FRC or RV

  • Position the patient in the center of the CT scanner gantry, isocenter,

  • Acquire a 3D dataset of the lungs with sub-millimeter near isotropic resolution in the x, y, and z axis

  • Use an optimal reconstruction kernel

  • Use as short a single breath hold as possible.

  • Use a reconstruction field of view that includes just the lungs.

  • Do all of this accurately and precisely across multiple CT manufacturers and CT scanner models

  • Use the lowest possible x-ray dose that meets the needs of a given research study.

We will now discuss each of the above points in more detail. The largest variation in lung attenuation is not driven by differences in CT scanner hardware or software but is driven by the ability of the patient to inspire or expire to a given lung volume, maintain that lung volume for the duration of the CT scan, 12 seconds or less, and not physically move while the CT scanner is acquiring image data. There are three lung volumes that are commonly used for QCT studies of the lung, total lung capacity (TLC), functional residual volume (FRC) and residual volume (RV). The two approaches that are used are 1) use a volume controller to physically determine at what lung volume the patient is holding their breath and 2) carefully coach the patient to the desired lung volume before beginning the scan. The first approach is the most precise and accurate. The second approach is the most practical. Depending on the goals of the particular research study either method may be used36, 37. Figure 1 shows a technologist carefully instructing a research subject. Table 2 shows the written breathing instructions that are used in the SPIROMICS protocol which is designed for use in large multi-center trials where most of the study sites do not have access to lung volume controllers.

Figure 1.

Figure 1

This is a figure of the technologist carefully instructing on the imaging technique and breathing instructions.

Patient positioning in the CT scanner is also very important. This is not as big an issue in qualitative 3D CT imaging but is essential in QCT. The CT scanner performs a number of calibration procedures including scanning without anything in the scanner imaging volume and also scanning manufacturer provided test objects (phantoms) to correct any drift in the CT attenuation values based on temporal variations in x-ray tube beam, x-ray detectors and associated electronics. This calibration process assumes that a patient will be positioned in the center of the CT gantry or isocenter when they are scanned. The corrections that the calibration process builds into the raw image data will not work properly if the patient is not in the center of the CT scanner aperture. Figure 2, illustrates the correct positioning of the patient in the CT scanner aperture.

Figure 2.

Figure 2

This figure illustrates the proper positioning of a patient in the CT scanner so that they are in the center of the scanner aperture.

The scan time is picked to be as short as possible so that the likelihood that the patient will be able to hold their breath is increased. Shortest scan time can be achieved be using the fastest gantry rotation time, maximum number of channels present and the highest pitch available which is a function of table speed and gantry rotation time. There are limitations if we want the very best quantitative data from the CT images. The accuracy of the CT attenuation values are dependent on having adequate sampling of the entire volume scanned. To insure accurate CT attenuation values the pitch setting needs to be no greater than 1, 1 is usually prescribed. The rotation time is as short as possible usually no greater than 0.5 seconds and often less than 0.3 seconds on the latest scanners. The most important factor is to be sure to have 64 channels or more available on the multi detector CT (MDCT) scanners included in the trial since this determines how much z axis coverage there is for a given pitch and rotation time.

The signal to noise ratio desired in the acquisition of the CT image data is inversely proportional to the radiation dose the patient receives, e.g. more radiation provides greater signal to noise ratio. There is clearly a need to keep the patient radiation dose to a minimum but also provide adequate signal to noise ratio for the study so that meaningful CT attenuation values are obtained and can be used to further research that may help the individual subjects/patients as well as other people with conditions like COPD or Asthma. For a given CT scanner hardware and software configuration the x-ray radiation dose is determined by the product of the tube current and total exposure time and also the maximum voltage, kVp, applied to the x-ray tube. Typically the QCT lung scannning protocol for a single x-ray tube source uses a kVp of 120 keV. This is the most common value chosen in studies of COPD and Asthma. It is important that all subjects/patients are scanned at the same kVp since changing the kVp will change the linear attenuation properties of matter and so change the values of the measured CT linear attenuation values assigned to the lung voxels independent of any other factor. The value of the tube current exposure time product, mAs, is very important in determining signal to noise ratio as well as radiation dose to the patient. The value of the mAs used is proportional to the amount of photons generated by the x-ray tube anode and so mAs is directly proportional to the patient x-ray radiation exposure from the CT scan. Increasing the mAs will increase the radiation exposure to the patient being scanned. Typical mAs values used in various QCT studies of the lung vary from a low value of 40 mAs for lower dose scans to 200 mAs for moderate dose scans. The radiation dose for a 40 mAs QCT lung scan is approximately 1.5 mSv and for a 200 mAs QCT lung scan is approximately 8 mSv assuming a 64 channel MDCT is used with weighted filtered back projection type image reconstruction. The larger the patient’s BMI the greater the mAs needs to be provide enough x-ray photons to the x-ray detector since the larger mass of the patient results in greater attenuation of the x-ray photons produced. This can be achieved by increasing or decreasing the mAs given a certain range of BMI values for the patients that are being scanned. The SPIROMICS CT scanning protocol adjusts the mAs based on the value of the patients BMI, Table 1. Small BMI subjects get less radiation but still achieve the desired signal to noise ratio in the CT images. Large BMI subjects receive more radiation so that the signal to noise ratio in the acquired QCT images are comparable to the values in the small and normal BMI subjects.

The reconstruction process is very important to insure that the CT data obtained accurately represents the true attenuating properties of the lung tissue that has been scanned. The most common reconstruction process in medical x-ray MDCT is the weighted filtered back projection method. The weighting factor is unique to each reconstruction kernel. This kernel needs to have no edge enhancement or image smoothing. Typical qualitative CT images of the lungs use a reconstruction kernel that has edge enhancement to bring out the small details of lung anatomy but at the expense of increased image noise and reduced accuracy of the CT attenuation values. Similarly, if a reconstruction kernel is used that smoothed the image than there is a decrease in the accuracy of the reconstruction kernel. The major CT manufacturers at this time have agreed that they will provide a neutral kernel that does not introduce edge enhancement or image smoothing and so will provide the most accurate values for the CT attenuation values that are obtained. Siemens HealthCare calls this the B35 kernel and GE Healthcare calls this the Standard kernel. Phillips Healthcare calls this the B kernel. For Toshiba scanners, the kernel FC01 is considered the standard kernel for quantitative lung imaging. A neutral kernel is used for QCT Lung studies of COPD and Asthma patients.

The next important issue in the QCT scanning process is CT scanner calibration. Quality control of the CT images must use CT scanner test objects (phantoms) to provide frequent periodic checks on the CT scanner calibration to assure precise and accurate CT numbers are obtained. This is done using manufacturer supplied test objects or phantoms and, in the case of QCT research into COPD and Asthma, the COPDGene 1 test object38, Figure 3. Typically CT calibration is done on a daily or weekly basis using the manufacturers test object and procedures. A dedicated test object that looks closely at the CT scanner’s ability to produce accurate CT attenuation values for the lung are also important and typically this sort of test object is scanned at the start of the study on every CT scanner to be used in the study so that accurate and precise CT attenuation values are obtained on all subjects right at the start of a study. This specialized test object is then scanned at monthly intervals on each CT scanner in the study. The results of these test objects scans are immediately sent to a central image processing facility that has special expertise and software to analyze the results and make sure that all the CT scanners in the study are functioning properly. If anomalies are detected in the test object CT image data the center is notified and the CT scanner in question is not used until it is re-calibrated.

Figure 3.

Figure 3

The COPDGene 1 phantom is illustrated in this figure.

Imaging Processing Software

Once the QCT image data is obtained using the procedures outlined above it is necessary to extract the quantitative information out of the 3D QCT image dataset using specially trained image analysts and specialized image processing software.

Typically the image analyst will access a central image archive to load a given subjects CT image data for analysis. This image data has been acquired and stored in the medical imaging standard data format, DICOM 3.0 Part 5. The image analysts will quality control the image data. It is important for trained image analysts to provide comprehensive quality control of the acquired image data, with rapid communication of quality defects to the submitting site. This includes evaluating all of the following important components:

  • Inspiratory or expiratory images were acquired at the appropriate lung volume

  • Motion artifact is absent

  • All of the lung anatomy was imaged.

  • The reconstructed image’s field of view includes all of the lungs, but as little of the adjacent chest wall and surrounding air as possible.

The next step is to use the specialized image processing software to segment the central airways and the lungs from the rest of the thoracic anatomy, Figure 4. The image analyst will check the segmented lung data output from the image processing software to make sure the boundaries of the lungs and corresponding airways were accurately identified. If there are any discrepancies than the image analyst will make the corrections and save the updated image data. The remainder of the process is done automatically by the image processing software. This includes determining the amount of lung that is less than −950 HU in density on TLC QCT scans. It also may include determining the amount of lung that is less than −856 HU in density on the FRC/RV QCT scans. Central airway wall thickening is also determined automatically by the software and includes values such as luminal area, luminal diameter, wall area, wall area percent and wall thickness. All of these important image parameters can be determined for whole lung, individual lungs and individual lung lobes. This information is then exported to an Excel spreadsheet for further analysis.

Figure 4.

Figure 4

This figure illustrates the user interface and segmented lung and airway tree output from a typical image processing program that is used for QCT of the lung.

Summary

QCT imaging of the lung can provide important metrics or phenotypic measurements of lung disease. In order to obtain accurate and precise image based quantitative CT metrics it is important to design and follow a standardized CT scanning protocol and to adhere to a robust CT scanning quality control program using standardized CT scanner test objects. Suitable image processing software must be used to extract the necessary information from the CT images. QCT imaging derived metrics of lung disease can then be combined with other measures of lung disease to increase our understanding of lung disease and increase our ability to design effective therapies.

Table 1.

The ranges of BMI for patients in the SPIROMICS QCT scanning protocol and the corresponding mas, CTDIvol and effective radiation dose are illustrated in this table.

Effective mAs Range BMI Range CTDIvol (mGy)
~150 >30 11.4
~100 20 to 30 7.6
~50 <20 4.2

Table 2.

SCANNING:
Use the breathing instructions to perform:
  • A practice breathing session

  • Scouts – as needed- to position the FOV to cover the entire lung and as little soft tissue as possible

  • The inspiration CT scan (TLC)

Inspiratory CT (TLC)
SCANNING:
Use the breathing instructions to perform:
  • A practice breathing session

  • Scouts as – needed- to position the FOV to cover the entire lung and as little soft tissue as possible

  • The inspiration CT scan (TLC)

Expiratory CT (FRC)

BREATHING INSTRUCTIONS:
For this scan, I am going to ask you to take a couple of deep breaths in and out before we have you breathe all the way in and hold your breath
BREATHING INSTRUCTIONS:
For this scan, I am going to ask you to take a couple of deep breaths in and out before we have you breathe out and hold your breath
Ok, lets get started,
Take a deep breath in (watch chest to ensure a deep breath in)
Let it out (watch chest to ensure air is out)
Take a deep breath in (watch chest to ensure a deep breath in)
Let it out (watch chest to ensure air is out)
Now breathe all the way IN…IN…IN(watch chest to ensure a deep breath in as far as possible)
Keep holding your breath – DO NOT BREATHE!
At end of scan or practice – Breathe and relax
Take a deep breath in (watch chest to ensure a deep breath in)
Let it out (watch chest to ensure air is out)
Take a deep breath in (watch chest to ensure a deep breath in)
Let it out (watch chest to ensure air is out)
Take another deep breathe in (watch chest to ensure a deep breath in)
Now release your breath out and stop breathing (make sure subject is holding out before starting the scan)
Keep holding your breath – DO NOT BREATHE! (count 10 seconds or Scan)
Breathe and relax (Give the patient a few relax breaths. After the practice session, talk to the patient to ensure they understand and will tolerate the breath hold. If they cannot hold their breath instruct them to do the best they can and set scanner to scan base to apex.

Footnotes

Conflict of Interest:

JDN and JS are paid consultants for VIDA Diagnostics, Inc. EAH is co-founder and shareholder in VIDA Diagnostics, Inc. which is a company that makes lung image processing software.

References

  • 1.Zach JA, Newell JD, Jr, Schroeder J, et al. Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults. Invest Radiol. 2012;47:596–602. doi: 10.1097/RLI.0b013e318262292e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.da Silva EC, Silva AC, de Paiva AC, et al. Diagnosis of solitary lung nodules using the local form of Ripley’s K function applied to three-dimensional CT data. Comput Methods Programs Biomed. 2008;90:230–9. doi: 10.1016/j.cmpb.2008.02.003. [DOI] [PubMed] [Google Scholar]
  • 3.Grydeland TB, Thorsen E, Dirksen A, et al. Quantitative CT measures of emphysema and airway wall thickness are related to D(L)CO. Respir Med. 2011;105:343–51. doi: 10.1016/j.rmed.2010.10.018. [DOI] [PubMed] [Google Scholar]
  • 4.Xie X, de Jong PA, Oudkerk M, et al. Morphological measurements in computed tomography correlate with airflow obstruction in chronic obstructive pulmonary disease: systematic review and meta-analysis. Eur Radiol. 2012;22:2085–93. doi: 10.1007/s00330-012-2480-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Besir FH, Mahmutyazicioglu K, Aydin L, et al. The benefit of expiratory-phase quantitative CT densitometry in the early diagnosis of chronic obstructive pulmonary disease. Diagn Interv Radiol. 2012;18:248–54. doi: 10.4261/1305-3825.DIR.4365-11.3. [DOI] [PubMed] [Google Scholar]
  • 6.Stolk J, Putter H, Bakker EM, et al. Progression parameters for emphysema: a clinical investigation. Respir Med. 2007;101:1924–30. doi: 10.1016/j.rmed.2007.04.016. [DOI] [PubMed] [Google Scholar]
  • 7.Bakker ME, Stolk J, Putter H, et al. Variability in densitometric assessment of pulmonary emphysema with computed tomography. Invest Radiol. 2005;40:777–83. doi: 10.1097/01.rli.0000186418.31139.21. [DOI] [PubMed] [Google Scholar]
  • 8.Busacker A, Newell JD, Jr, Keefe T, et al. A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. Chest. 2009;135:48–56. doi: 10.1378/chest.08-0049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jain N, Covar RA, Gleason MC, et al. Quantitative computed tomography detects peripheral airway disease in asthmatic children. Pediatr Pulmonol. 2005;40:211–8. doi: 10.1002/ppul.20215. [DOI] [PubMed] [Google Scholar]
  • 10.Newman KB, Lynch DA, Newman LS, et al. Quantitative computed tomography detects air trapping due to asthma. Chest. 1994;106:105–9. doi: 10.1378/chest.106.1.105. [DOI] [PubMed] [Google Scholar]
  • 11.Xu Y, van Beek EJ, Hwanjo Y, et al. Computer-aided classification of interstitial lung diseases via MDCT: 3D adaptive multiple feature method (3D AMFM) Acad Radiol. 2006;13:969–78. doi: 10.1016/j.acra.2006.04.017. [DOI] [PubMed] [Google Scholar]
  • 12.Hoffman EA, Reinhardt JM, Sonka M, et al. Characterization of the interstitial lung diseases via density-based and texture-based analysis of computed tomography images of lung structure and function. Acad Radiol. 2003;10:1104–18. doi: 10.1016/s1076-6332(03)00330-1. [DOI] [PubMed] [Google Scholar]
  • 13.Uppaluri R, Hoffman EA, Sonka M, et al. Interstitial lung disease: A quantitative study using the adaptive multiple feature method. Am J Respir Crit Care Med. 1999;159:519–25. doi: 10.1164/ajrccm.159.2.9707145. [DOI] [PubMed] [Google Scholar]
  • 14.Beinert T, Kohz P, Seemann M, et al. Spirometrically controlled high resolution computed tomography - quantitative assessment of density distribution in patients with diffuse fibrosing alveolitis. Eur J Med Res. 1996;1:269–72. [PubMed] [Google Scholar]
  • 15.Hartley PG, Galvin JR, Hunninghake GW, et al. High-resolution CT-derived measures of lung density are valid indexes of interstitial lung disease. J Appl Physiol. 1994;76:271–7. doi: 10.1152/jappl.1994.76.1.271. [DOI] [PubMed] [Google Scholar]
  • 16.Sieren JC, Smith AR, Thiesse J, et al. Exploration of the volumetric composition of human lung cancer nodules in correlated histopathology and computed tomography. Lung Cancer. 2011;74:61–8. doi: 10.1016/j.lungcan.2011.01.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kawata Y, Niki N, Ohmatsu H, et al. Quantitative classification based on CT histogram analysis of non-small cell lung cancer: correlation with histopathological characteristics and recurrence-free survival. Med Phys. 2012;39:988–1000. doi: 10.1118/1.3679017. [DOI] [PubMed] [Google Scholar]
  • 18.Ma SH, Le HB, Jia BH, et al. Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression. BMC Cancer. 2008;8:186. doi: 10.1186/1471-2407-8-186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Petkovska I, Shah SK, McNitt-Gray MF, et al. Pulmonary nodule characterization: a comparison of conventional with quantitative and visual semi-quantitative analyses using contrast enhancement maps. Eur J Radiol. 2006;59:244–52. doi: 10.1016/j.ejrad.2006.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Potente G, D’Andrea V, Cantisani V, et al. Small solitary pulmonary nodules: assessment of enhancement and enhancement patterns in benign and malignant tumours by high resolution computed tomography. Chirurgia italiana. 1999;51:113–20. [PubMed] [Google Scholar]
  • 21.Zhang M, Kono M. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology. 1997;205:471–8. doi: 10.1148/radiology.205.2.9356631. [DOI] [PubMed] [Google Scholar]
  • 22.Zerhouni EA, Boukadoum M, Siddiky MA, et al. A standard phantom for quantitative CT analysis of pulmonary nodules. Radiology. 1983;149:767–73. doi: 10.1148/radiology.149.3.6647853. [DOI] [PubMed] [Google Scholar]
  • 23.Vinogradskiy YY, Castillo R, Castillo E, et al. Use of weekly 4DCT-based ventilation maps to quantify changes in lung function for patients undergoing radiation therapy. Med Phys. 2012;39:289–98. doi: 10.1118/1.3668056. [DOI] [PubMed] [Google Scholar]
  • 24.Palma DA, van Sornsen de Koste J, Verbakel WF, et al. Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50 patients. Int J Radiat Oncol Biol Phys. 2011;81:974–8. doi: 10.1016/j.ijrobp.2010.07.025. [DOI] [PubMed] [Google Scholar]
  • 25.Blom-Goldman U, Svane G, Wennberg B, et al. Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer. Acta Oncol. 2007;46:187–93. doi: 10.1080/02841860600949586. [DOI] [PubMed] [Google Scholar]
  • 26.Mah K, Van Dyk J. Quantitative measurement of changes in human lung density following irradiation. Radiother Oncol. 1988;11:169–79. doi: 10.1016/0167-8140(88)90253-8. [DOI] [PubMed] [Google Scholar]
  • 27.Fuld MK, Halaweish AE, Haynes SE, et al. Pulmonary Perfused Blood Volume with Dual-Energy CT as Surrogate for Pulmonary Perfusion Assessed with Dynamic Multidetector CT. Radiology. 2012 doi: 10.1148/radiol.12112789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ding K, Cao K, Fuld MK, et al. Comparison of image registration based measures of regional lung ventilation from dynamic spiral CT with Xe-CT. Med Phys. 2012;39:5084–98. doi: 10.1118/1.4736808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Fernandez-Bustamante A, Easley RB, Fuld M, et al. Regional aeration and perfusion distribution in a sheep model of endotoxemic acute lung injury characterized by functional computed tomography imaging. Crit Care Med. 2009;37:2402–11. doi: 10.1097/CCM.0b013e3181a02354. [DOI] [PubMed] [Google Scholar]
  • 30.Fuld MK, Easley RB, Saba OI, et al. CT-measured regional specific volume change reflects regional ventilation in supine sheep. J Appl Physiol. 2008;104:1177–84. doi: 10.1152/japplphysiol.00212.2007. [DOI] [PubMed] [Google Scholar]
  • 31.Wang Z, Gu S, Leader JK, et al. Optimal threshold in CT quantification of emphysema. Eur Radiol. 2012 doi: 10.1007/s00330-012-2683-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Shah SK, McNitt-Gray MF, Rogers SR, et al. Computer aided characterization of the solitary pulmonary nodule using volumetric and contrast enhancement features. Acad Radiol. 2005;12:1310–9. doi: 10.1016/j.acra.2005.06.005. [DOI] [PubMed] [Google Scholar]
  • 33.Mets OM, Zanen P, Lammers JW, et al. Early Identification of Small Airways Disease on Lung Cancer Screening CT: Comparison of Current Air Trapping Measures. Lung. 2012;190:629–33. doi: 10.1007/s00408-012-9422-8. [DOI] [PubMed] [Google Scholar]
  • 34.Donohue KM, Hoffman EA, Baumhauer H, et al. Cigarette smoking and airway wall thickness on CT scan in a multi-ethnic cohort: the MESA Lung Study. Respir Med. 2012;106:1655–64. doi: 10.1016/j.rmed.2012.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Mets OM, Willemink MJ, de Kort FP, et al. The effect of iterative reconstruction on computed tomography assessment of emphysema, air trapping and airway dimensions. Eur Radiol. 2012;22:2103–9. doi: 10.1007/s00330-012-2489-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Fuld MK, Grout RW, Guo J, et al. Systems for lung volume standardization during static and dynamic MDCT-based quantitative assessment of pulmonary structure and function. Acad Radiol. 2012;19:930–40. doi: 10.1016/j.acra.2012.03.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Geyer LL, Scherr M, Korner M, et al. Imaging of acute pulmonary embolism using a dual energy CT system with rapid kVp switching: initial results. Eur J Radiol. 2012;81:3711–8. doi: 10.1016/j.ejrad.2011.02.043. [DOI] [PubMed] [Google Scholar]

RESOURCES